FDA clears Genetesis’ CardioFlux biomagnetic cardiac imager

FDA clears Genetesis’ CardioFlux biomagnetic cardiac imager

Source: 
Mass Device
snippet: 

Genetesis said last Friday it won FDA 510(k) clearance for its CardioFlux biomagnetic cardiac imaging platform.